Evidence map›Paper›PMID 31475484›Full record

ArticleMolecular genetics & genomic medicine2019

Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes.

Muhammad M Rahman, Km Furkan Uddin, Nesreen K Al Jezawi, Noushad Karuvantevida, Hosneara Akter, Nushrat J Dity, Md Ashiquir Rahaman, Maksuda Begum, Md Atikur Rahaman, Md Abdul Baqui and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 5 countries.

Muhammad M RahmanBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Km Furkan UddinNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Nesreen K Al JezawiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Noushad KaruvantevidaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Hosneara AkterNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Nushrat J DityNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Md Ashiquir RahamanNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Maksuda BegumNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Md Atikur RahamanNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Md Abdul BaquiNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Zeena SalwaSquare Hospital Ltd., Dhaka, Bangladesh.
Serajul IslamIBN Sina Medical Imaging Center, Dhaka, Bangladesh.
Marc Woodbury-SmithInstitute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
Mohammed BasiruzzamanNeuroGen Technologies Ltd., Dhaka, Bangladesh.
Mohammed UddinCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.ORCID 0000-0001-6867-5803
Dhaka Medical College and Hospital · BDHoly Family Red Crescent Medical CollegeHospital for Sick Children · CABangladesh Medical University · BDBharathidasan University · INMohammed Bin Rashid University of Medicine and Health Sciences · AESquare Hospitals · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntellectual disability (ID) is a complex condition that can impact multiple domains of development. The genetic contribution to ID's etiology is significant, with more than 100 implicated genes and loci currently identified. The majority of such variants are rare and de novo genetic mutations.

methodsWe have applied whole-genome microarray to identify large, rare, clinically relevant copy number variants (CNVs). We have applied well-established algorithms for variants call. Quantitative polymerase chain reaction (qPCR) was applied to validate the variants using three technical replicates for each family member. To assess whether the copy number variation was due to balanced translocation or mosaicism, we further conducted droplet digital PCR (ddPCR) on the whole family. We have, as well, applied "critical-exon" mapping, human developmental brain transcriptome, and a database of known associated neurodevelopmental disorder variants to identify candidate genes.

resultsHere we present two siblings who are both impacted by a large terminal duplication and a deletion. Whole-genome microarray revealed an 18.82 megabase (MB) duplication at terminal locus (7q34-q36.3) of chromosome 7 and a 3.90 MB deletion impacting the terminal locus (15q26.3) of chromosome 15. qPCR and ddPCR experiments confirmed the de novo origin of the variants and the co-occurrence of these two de novo events among the siblings, but their absence in both parents, implicates an unbalanced translocation that could have mal-segregated among the siblings or a possible germline mosaicism. These terminal events impact IGF1R, CNTNAP2, and DPP6, shown to be strongly associated with neurodevelopmental disorders. Detailed clinical examination of the siblings revealed the presence of both shared and distinct phenotypic features.

conclusionsThis study identified two large rare terminal de novo events impacting two siblings. Further phenotypic investigation highlights that even in the presence of identical large high penetrant variants, spectrum of clinical features can be different between the siblings.

Indexed as

ChildChild, PreschoolChromosomes, Human, Pair 15Chromosomes, Human, Pair 7Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesFemaleGene DeletionGene DuplicationGenetic VariationGonadsHumansIntellectual DisabilityMaleMembrane ProteinsMosaicismNerve Tissue ProteinsCNTNAP2 protein, humanDipeptidyl-Peptidases and Tripeptidyl-PeptidasesDPP6 protein, humanIGF1R protein, humanMembrane ProteinsNerve Tissue ProteinsPotassium ChannelsReceptor, IGF Type 1copy number variationgonadal mosaicismintellectual disability

Identifiers

PMID31475484
PMCPMC6785528
OpenAlexW2970263042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.